Dr. Perez is a researcher at IDOR and Associate Professor of the Internal Medicine Department at the Federal University of Rio de Janeiro. Her group investigates new diagnostic and prognostic tools in liver diseases, especially non-alcoholic fatty liver disease and complications of liver cirrhosis. Her research focuses on analyzing new biomarkers, the performance of magnetic resonance imaging of the liver, and other clinical, laboratory, and imaging tests in the diagnostic and prognostic evaluation of liver diseases.
Keywords: cirrhosis, fatty liver, liver fibrosis, biomarkers, magnetic resonance
Pozzobon FM, Perazzo H, Bozza FA, Rodrigues RS, de Mello Perez R, Chindamo MC. Liver injury predicts overall mortality in severe COVID-19: a prospective multicenter study in Brazil. Hepatol Int. 2021 Apr;15(2):493-501.
Parente DB, Perazzo H, Paiva FF, Campos CFF, Saboya CJ, Pereira SE, Silva FDE, Rodrigues RS, Perez RM. Higher cut-off values of non-invasive methods might be needed to detect moderate-to-severe steatosis in morbid obese patients: a pilot study. Sci Rep. 2020 Sep 14;10(1):15007.
Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez RM, Rodrigues RS. Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World J Hepatol. 2020 Sep 27;12(9):661-671.
Perazzo H, Fernandes FF, Castro Filho EC, Perez RM. Points to be considered when using transient elastography for diagnosis of portal hypertension according to the Baveno’s VI consensus. J Hepatol. 2015 Oct;63(4):1048-9.
Parente DB, Rodrigues RS, Paiva FF, Oliveira Neto JA, Machado-Silva L, Lanzoni V, Campos CF, Eiras-Araujo AL, do Brasil PE, Garteiser P, Gomes MB, de Mello Perez R. Is MR spectroscopy really the best MR-based method for the evaluation of fatty liver in diabetic patients in clinical practice? PLoS One. 2014 Nov 26;9(11):e112574.